During the past decade, Universita' Degli Studi La Sapienza-Ist.Di Ematologia; Dip Biot Cel e Ematol conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universita' Degli Studi La Sapienza-Ist.Di Ematologia; Dip Biot Cel e Ematol" #1 sponsor was "Fondazione Italiana Linfomi ONLUS" with 7 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 2 trials sponsored, "Gruppo Italiano Trapianto di Midollo Osseo" with 2 trials sponsored and "European Myeloma Network" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universita' Degli Studi La Sapienza-Ist.Di Ematologia; Dip Biot Cel e Ematol" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 1 trials as a collaborator, "Fondazione EMN Italy Onlus" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "GRADE Onlus" with 1 trials as a collaborator and "LMU Klinikum" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Universita' Degli Studi La Sapienza-Ist.Di Ematologia; Dip Biot Cel e Ematol" are "Mantle Cell Lymphoma" (3 trials), "Diffuse Large B-Cell Lymphoma" (2 trials), "Myelofibrosis" (2 trials), "Non-Hodgkin's Lymphoma" (2 trials) and "Acute Myeloblastic Leukemia" (1 trials). Many other conditions were trialed in "Universita' Degli Studi La Sapienza-Ist.Di Ematologia; Dip Biot Cel e Ematol" in a lesser frequency.

Most popular intervention types in "Universita' Degli Studi La Sapienza-Ist.Di Ematologia; Dip Biot Cel e Ematol" are "Drug" (21 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (5 trials), "Bendamustine" (4 trials), "Cyclophosphamide" (4 trials), "Obinutuzumab" (3 trials) and "Doxorubicin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universita' Degli Studi La Sapienza-Ist.Di Ematologia; Dip Biot Cel e Ematol" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Universita' Degli Studi La Sapienza-Ist.Di Ematologia; Dip Biot Cel e Ematol". 1 are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Universita' Degli Studi La Sapienza-Ist.Di Ematologia; Dip Biot Cel e Ematol, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universita' Degli Studi La Sapienza-Ist.Di Ematologia; Dip Biot Cel e Ematol, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".